
Jeffrey Popma MD
Adult Congenital Heart Disease, Interventional Cardiology
Professor, Medicine-Beth Israel Deaconess Medical Center, Harvard Medical School
Join to view full profile
185 Pilgrim Rd# BAKER4Boston, MA 02215
Phone+1 617-632-9210
Fax+1 617-632-7460
Dr. Popma is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MichiganFellowship, Cardiovascular Disease, 1989 - 1990
University of Texas Southwestern Medical CenterFellowship, Cardiovascular Disease, 1986 - 1989
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1982 - 1986
University of California (San Francisco)/FresnoInternship, Transitional Year, 1981 - 1982
Indiana University School of MedicineClass of 1981
Certifications & Licensure
MA State Medical License 1998 - 2027
MD State Medical License 1991 - 1999
DC State Medical License 1991 - 1998
MI State Medical License 1989 - 1993
TX State Medical License 1983 - 1989
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Online Medical Record, Beth Israel Deaconess Medical Center, 2012-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Quality Data Center, Massachusetts eHealth Collaborative (MAeHC), 2012-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Online Medical Record, Beth Israel Deaconess Medical Center, 2012-2014, 2016-2017
Clinical Trials
- Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement Start of enrollment: 2010 Dec 10
- Safety and Efficacy Continued Access Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in Very High Risk Subjects and High Risk Subjects Who Need Aortic Valve Replacement Start of enrollment: 2012 Feb 21
- Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).
Publications & Presentations
PubMed
- Estimating Redo Aortic Valve Replacement After TAVR: Kaplan-Meier vs Cumulative Incidence.Harun Kundi, Graeme Hickey, David J Cohen, Martin B Leon, Jeffrey J Popma
Journal of the American College of Cardiology. 2026-10-06 - Temporal Trends in Mitral Valve Repair Procedures and Outcomes Among Older U.S. Adults.Philipp von Stein, David J Cohen, Martin B Leon, Alexandra Popma, Jennifer von Stein
JACC. Advances. 2026-09-23 - Patterns and Timing of Sequential Transcatheter Valve Interventions After Index TAVR, M-TEER, and TMVR: A Nationwide Medicare Analysis.Nicolò Azzola Guicciardi, Jeffrey Popma, Martin B Leon, David J Cohen, Roberto Lorusso
Structural Heart. 2026-08-01
Journal Articles
- Transcatheter Aortic Valve Replacement in Low-Risk Patients with Bicuspid Aortic Valve StenosisJohn K Forrest, Basel Ramlawi, Neal S Kleiman, Stanley J Chetcuti, Hector I Michelena, Jeffrey A Skiles, Jeffrey J Popma, Michael J Reardon, JAMA Cardiology
- Original Research Self-Expanding Transcatheter Aortic Valve Replacement in Patients with Low-Gradient Aortic StenosisHarold L Dauerman, Jon R Resar, Steven J Yakubov, P Michael Grossman, Stanley J Chetcuti, G Michael Deeb, Jeffrey J Popma, Jae K Oh, ScienceDirect
- Original Investigation Neurological Complications After Transcatheter Versus Surgical Aortic Valve Replacement in Intermediate-Risk PatientsJeffrey J Popma, Thomas G Gleason, William H Ryan, Neal S Kleiman, Tanvir Bajwa, David L Brown, ScienceDirect
Lectures
- Protected PCI: A Contemporary Look at Clinical Data from cVADCRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/26/2019
- Large-Hole Transfemoral Closure I: The PerQseal DeviceCRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/27/2019
- Acquiring Advanced - Complication ManagementCRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/25/2019
Press Mentions
MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDedJuly 3rd, 2025
Positive Results with Carillon Mitral Device Seen in Real-World RegistriesFebruary 21st, 2025
Three-Year Data Presented from Medtronic Evolut Low Risk Trial of TAVR Versus SAVRMarch 5th, 2023
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: